Globally, private equity markets have moderated in the first half of 2026 as new and ongoing geopolitical developments are shifting the calculus ...
Across four parts of the “FDA Watch” podcast series featuring Skadden partners and counsel, legal and industry panelists convened between March ...
The One Big Beautiful Bill Act (OBBBA), when signed into law on July 4, 2025, imposed a number of new restrictions and requirements on energy ...
In one of the most significant class action rulings in website tracking litigation to date, a California federal court just ...
On June 2, 2026, the Office of the U.S. Trade Representative (USTR) released its report on Section 301 investigations into ...
In this edition of Skadden’s quarterly Insights, we examine the deal terms being structured to align parties’ interests in acquisitions of ...
Antitrust authorities in the United States, Europe and Asia have shown increased openness to merger remedies, including behavioral ones.
This week delivered the kind of headline that had international trade compliance practitioners’ heads swimming: a 14‑point ...
After the U.S. Supreme Court struck down President Trump’s IEEPA tariffs as unconstitutional in February 2026, the Court ...
Spinal cord injuries from traumatic accidents can have devastating consequences. They can lead to chronic pain and permanent ...
New York lawmakers recently passed several bills that would impose new AI reporting and disclosure requirements on businesses ...
Consolidated Omnibus Budget Reconciliation Act (COBRA) compliance often gets treated as a “set it and forget it” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results